Back to Search Results
Image Place holder

James Grichnik, MD, PhD

 
Specialty: Dermatology
Program: Cutaneous Oncology

Call 1-888-663-3488

Call 1-888-663-3488


Locations:
Overview

Cancer Focus: Basal Cell Carcinoma, Melanoma, Merkel Cell Carcinoma, Skin Cancer (Nonmelanoma), Squamous Cell Carcinoma

Dr. Grichnik is Chairman of USF Dermatology supporting and growing early detection and treatment efforts at H. Lee Moffitt Cancer Center within the USF outpatient system. He is internationally recognized melanoma expert with more than 30 years of experience in melanoma clinical care, melanoma imaging technologies, and basic laboratory research. He previously served as the Director of the Scully-Welsh Cancer Center part of the Cleveland Clinic system, Director of the Anna Fund Melanoma Program at Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, and the Director of the Melanocytic Diseases Section and Melanoma Surveillance/ Pigmented lesion Clinic within Dermatology at Duke University Medical Center


Education & Training

Residency:

  • Duke University Medical Center - Dermatology

Medical School:

  • Harvard Medical School - MD
Participating Trials

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.

Publications

  • Natarelli N, Hanlon K, Chen WS, Grichnik JM, Zager JS, Correa-Selm L. Reflectance confocal microscopic visualization of melanocytic bodies in the stratum corneum overlying acral lentiginous melanoma. Lasers Surg Med. 2023 Mar.55(3):253-256. Pubmedid: 36883986.
  • Correa-Selm L, Hanlon KL, Grichnik JM. Differentiating activated Langerhans cells and dendritic melanocytes using reflectance confocal microscopy: the limitations of diagnosing melanoma in vivo. Lancet. 2023 Feb.401(10376):590. Pubmedid: 36803434.
  • Natarelli N, Krenitsky A, Hennessey K, Moore S, Grichnik J. Efficacy and safety of topical treatments for seborrheic keratoses: a systematic review. J Dermatolog Treat. 2022 Nov.1-12. Pubmedid: 36215682.
  • Hanlon KL, Wei G, Braue J, Correa-Selm L, Grichnik JM. Improving dermal level images from reflectance confocal microscopy using wavelet-based transformations and adaptive histogram equalization. Lasers Surg Med. 2022 Mar.54(3):384-391. Pubmedid: 34633691.
  • Blumstein AJ, Hanlon KL, Chen WS, Elgart G, Grichnik JM, Correa-Selm L. Reflectance confocal findings in a large-cell acanthoma with histologic correlation. JAAD Case Rep. 2021 Oct.16:65-68. Pubmedid: 34522750. Pmcid: PMC8427221.
  • Hanlon KL, Correa-Selm LM, Grichnik JM. Application of 3-dimensional reflectance confocal microscopy: Melanocytic proliferations as three-dimensional models. J Am Acad Dermatol. 2021 Jun.84(6):1737-1739. Pubmedid: 32871164.
  • Hanlon KL, Shah KN, Grichnik JM. Color shift as a mechanism for depth modulation of skin images. J Am Acad Dermatol. 2021 Jul.85(1):252-254. Pubmedid: 32822801.
  • Cho-Vega JH, Cao T, Ledon J, Moller M, Avisar E, Elgart G, Tan JH, Fan YS, Grichnik JM. Diagnostic application of cyclin D1 fluorescent in situ hybridization for histologically undetermined early lesions of acral melanoma in situ: A case series. Ann Diagn Pathol. 2021 Feb.50:151681. Pubmedid: 33341705.
  • Hanlon K, Grichnik J, Correa-Selm L. Epidermal streaming seen in a seborrheic keratosis using reflectance confocal microscopy and histopathology correlation. JAAD Case Rep. 2019 Dec.5(12):1065-1067. Pubmedid: 31799353. Pmcid: PMC6881612.
  • Lackey AE, Glassman G, Grichnik J, McDonald J, Correa-Selm L. Repigmentation of gray hairs with lentigo maligna and response to topical imiquimod. JAAD Case Rep. 2019 Dec.5(12):1015-1017. Pubmedid: 31763424. Pmcid: PMC6864298.
  • Correa-Selm LM, Grichnik JM. PD1 inhibitors and hair repigmentation: A desirable new side effect. Dermatol Ther. 2018 Jan.31(1). Pubmedid: 29034554.
  • Nelson KC, Grossman D, Kim CC, Chen SC, Curiel-Lewandrowski CN, Grichnik JM, Kirkwood JM, Leachman SA, Marghoob AA, Swetter SM, Venna SS, Ming ME. Management strategies of academic pigmented lesion clinic directors in the United States. J Am Acad Dermatol. 2018 Aug.79(2):367-369. Pubmedid: 29307637.
  • Correa-Selm LM, Grichnik JM. Prevention of graying: Is KROX20 the solution?. Dermatol Ther. 2017 Sep.30(5). Pubmedid: 28796343.
  • Aldahan AS, Chen LL, Tsatalis JP, Grichnik JM. Optical Coherence Tomography Visualization of a Port-Wine Stain in a Patient With Sturge-Weber Syndrome. Dermatol Surg. 2017 Jun.43(6):889-891. Pubmedid: 28541265.
  • Bordelon JR, Grichnik JM. Molecular diagnosis of melanoma-have we arrived?. Dermatol Ther. 2016 Oct.28(6):405. Pubmedid: 26031627.
  • Hughes OB, Grichnik JM. Molecular machines mitigate melanoma. Dermatol Ther. 2016 Nov.29(6):397. Pubmedid: 27146009.
  • Bosshardt OP, Grichnik JM. Citrus and melanoma risk: better to consume with dinner?. Dermatol Ther. 2016 May.29(3):211. Pubmedid: 26439189.
  • Grichnik JM. The cell of origin of acral melanomas may be hiding in the sweat glands. Dermatol Ther. 2016 May.28(2):105-106. Pubmedid: 25832467.
  • Bordelon JR, Grichnik JM. TGF-β may control the switch between tumorigenic growth and "stem cell/mesenchymal" potentially drug-resistant states. Dermatol Ther. 2016 Mar.28(3):177-178. Pubmedid: 25649199.
  • Aldahan AS, Mlacker S, Shah VV, Chen LL, Nouri K, Grichnik JM. Utilization of Optical Coherence Tomography in the Evaluation of Cherry Hemangiomas. J Drugs Dermatol. 2016 Jun.15(6):713-714. Pubmedid: 27272077.
  • Leachman SA, Cassidy PB, Chen SC, Curiel C, Geller A, Gareau D, Pellacani G, Grichnik JM, Malvehy J, North J, Jacques SL, Petrie T, Puig S, Swetter SM, Tofte S, Weinstock MA. Methods of Melanoma Detection. Cancer Treat Res. 2016 Jan.167:51-105. Pubmedid: 26601859.
  • Madankumar R, Gumaste PV, Martires K, Schaffer PR, Choudhary S, Falto-Aizpurua L, Arora H, Kallis PJ, Patel S, Damanpour S, Sanchez MI, Yin N, Chan A, Sanchez M, Polsky D, Kanavy H, Grichnik JM, Stein JA. Acral melanocytic lesions in the United States: Prevalence, awareness, and dermoscopic patterns in skin-of-color and non-Hispanic white patients. J Am Acad Dermatol. 2016 Apr.74(4):724-30.e1. Pubmedid: 26803347.
  • Damanpour S, Grichnik JM. Conceptual approach to early melanoma detection: models, tools, issues and challenges. Melanoma Manag. 2015 Nov.2(4):327-337. Pubmedid: 30190861. Pmcid: PMC6094681.
  • Grichnik JM. Sildenafil may elevate melanoma risk. Dermatol Ther. 2015 May.27(5):313. Pubmedid: 25285874.
  • Bordelon JR, Sanchez MI, Grichnik JM. Melanomagenesis: multifaceted attacks on the genome. Exp Dermatol. 2015 Mar.24(3):175-176. Pubmedid: 25421308.
  • Schneider SL, Ross AL, Grichnik JM. Do inflammatory pathways drive melanomagenesis?. Exp Dermatol. 2015 Feb.24(2):86-90. Pubmedid: 25041143.
  • Kim CC, Swetter SM, Curiel-Lewandrowski C, Grichnik JM, Grossman D, Halpern AC, Kirkwood JM, Leachman SA, Marghoob AA, Ming ME, Nelson KC, Veledar E, Venna SS, Chen SC. Addressing the knowledge gap in clinical recommendations for management and complete excision of clinically atypical nevi/dysplastic nevi: Pigmented Lesion Subcommittee consensus statement. JAMA Dermatol. 2015 Feb.151(2):212-218. Pubmedid: 25409291.
  • Braun RP, Thomas L, Dusza SW, Gaide O, Menzies S, Dalle S, Blum A, Argenziano G, Zalaudek I, Kopf A, Rabinovitz H, Oliviero M, Perrinaud A, Cabo H, Pizzichetta M, Pozo L, Langford D, Tanaka M, Saida T, Perusquia Ortiz AM, Kreusch J, De Giorgi V, Piccolo D, Grichnik JM, Kittler H, Puig S, Malvehy J, Seidenari S, Stanganelli I, French L, Marghoob AA. Dermoscopy of acral melanoma: a multicenter study on behalf of the international dermoscopy society. Dermatology. 2014 Sep.227(4):373-380. Pubmedid: 24296632.
  • Sode T, Cao T, Elgart GW, Jiménez-Acosta F, Grichnik JM. Enhancing techniques to evaluate tumor margins. J Am Acad Dermatol. 2014 Oct.71(4):827-829. Pubmedid: 25219704.
  • Grichnik JM, Ross AL, Schneider SL, Sanchez MI, Eller MS, Hatzistergos KE. How, and from which cell sources, do nevi really develop?. Exp Dermatol. 2014 May.23(5):310-313. Pubmedid: 24588745.
  • Sanchez MI, Rabinovitz HS, Oliviero MC, Elgart GW, Perez C, Puig S, Malvehy J, Grichnik JM. Dark homogeneous streak dermoscopic pattern correlating with specific KIT mutations in melanoma. JAMA Dermatol. 2014 Jun.150(6):633-639. Pubmedid: 24695820.
  • Sanchez MI, Grichnik JM. Melanoma's high C>T mutation rate: is deamination playing a role?. Exp Dermatol. 2014 Aug.23(8):551-552. Pubmedid: 24815223.
  • Lindsey SF, Sanchez MI, Elgart GW, Milikowski C, Civantos FJ, Goldberg J, Grichnik JM. Malignant melanoma from a nevus of Ota in a pediatric patient with fatal outcome. J Am Acad Dermatol. 2013 Oct.69(4):e195-e197. Pubmedid: 24034399.
  • Jaimes N, Dusza SW, Quigley EA, Braun RP, Puig S, Malvehy J, Kittler H, Rabinovitz HS, Oliviero MC, Soyer HP, Grichnik JM, Korzenko A, Cabo H, Carlos-Ortega B, Ahlgrimm-Siess V, Kopf AW, Marghoob AA. Influence of time on dermoscopic diagnosis and management. Australas J Dermatol. 2013 May.54(2):96-104. Pubmedid: 23190378.
  • Lindsey SF, Byrnes DM, Eller MS, Rosa AM, Dabas N, Escandon J, Grichnik JM. Potential role of meiosis proteins in melanoma chromosomal instability. J Skin Cancer. 2013 Jul.2013:190109. Pubmedid: 23840955. Pmcid: PMC3694528.
  • Sanchez MI, Rabinovitz HS, Oliverio MC, Elgart GW, Grichnik JM. Confocal microscopy of challenging dermoscopic diagnoses. Arch Dermatol. 2012 Oct.148(10):1224. Pubmedid: 23069979.
  • Handler MZ, Ross AL, Shiman MI, Elgart GW, Grichnik JM. Potential role of human growth hormone in melanoma growth promotion. Arch Dermatol. 2012 Oct.148(10):1179-1182. Pubmedid: 23069955.
  • Blum A, Argenziano G, Bowling J, Giacomel J, Hofmann-Wellenhof R, Kreusch J, Zalaudek I, Grichnik J. Rorschach dermoscopy. Arch Dermatol. 2012 Nov.148(11):1342. Pubmedid: 23165857.
  • Dabas N, Byrnes DM, Rosa AM, Eller MS, Grichnik JM. Diagnostic role of chromosomal instability in melanoma. J Skin Cancer. 2012 Nov.2012:914267. Pubmedid: 23125934. Pmcid: PMC3483783.
  • Curiel-Lewandrowski C, Kim CC, Swetter SM, Chen SC, Halpern AC, Kirkwood JM, Leachman SA, Marghoob AA, Ming ME, Grichnik JM. Survival is not the only valuable end point in melanoma screening. J Invest Dermatol. 2012 May.132(5):1332-1337. Pubmedid: 22336950. Pmcid: PMC4575123.
  • Rosa AM, Dabas N, Byrnes DM, Eller MS, Grichnik JM. Germ cell proteins in melanoma: prognosis, diagnosis, treatment, and theories on expression. J Skin Cancer. 2012 Dec.2012:621968. Pubmedid: 23209909. Pmcid: PMC3503391.
  • Ross AL, Sanchez MI, Grichnik JM. Nevus senescence. ISRN Dermatol. 2012 Aug.2011:642157. Pubmedid: 22363855. Pmcid: PMC3262546.
  • Ross AL, Sanchez MI, Grichnik JM. Nevogenesis: a benign metastatic process?. ISRN Dermatol. 2012 Aug.2011:813513. Pubmedid: 22363860. Pmcid: PMC3262547.
  • Ross AL, Leder DE, Weiss J, Izakovic J, Grichnik JM. Genomic instability in cultured stem cells: associated risks and underlying mechanisms. Regen Med. 2011 Sep.6(5):653-662. Pubmedid: 21916599.
  • Shao H, Cai L, Grichnik JM, Livingstone AS, Velazquez OC, Liu ZJ. Activation of Notch1 signaling in stromal fibroblasts inhibits melanoma growth by upregulating WISP-1. Oncogene. 2011 Oct.30(42):4316-4326. Pubmedid: 21516124.
  • Bichakjian CK, Halpern AC, Johnson TM, Foote Hood A, Grichnik JM, Swetter SM, Tsao H, Barbosa VH, Chuang TY, Duvic M, Ho VC, Sober AJ, Beutner KR, Bhushan R, Smith Begolka W. Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology. J Am Acad Dermatol. 2011 Nov.65(5):1032-1047. Pubmedid: 21868127.
  • Hatzistergos KE, Blum A, Ince T, Grichnik JM, Hare JM. What is the oncologic risk of stem cell treatment for heart disease?. Circ Res. 2011 May.108(11):1300-1303. Pubmedid: 21617132. Pmcid: PMC3390911.
  • Wang H, Moss RH, Chen X, Stanley RJ, Stoecker WV, Celebi ME, Malters JM, Grichnik JM, Marghoob AA, Rabinovitz HS, Menzies SW, Szalapski TM. Modified watershed technique and post-processing for segmentation of skin lesions in dermoscopy images. Comput Med Imag Grap. 2011 Mar.35(2):116-120. Pubmedid: 20970307. Pmcid: PMC3183575.
  • Grichnik JM. Age-dependent differences in growth curves for distinct melanocytic nevus subsets. Arch Dermatol. 2011 Jun.147(6):731-732. Pubmedid: 21690539.
  • Ross AL, Sanchez MI, Grichnik JM. Molecular nevogenesis. Dermatol Res Pract. 2011 Jul.2011:463184. Pubmedid: 21754924. Pmcid: PMC3130972.
  • Monheit G, Cognetta AB, Ferris L, Rabinovitz H, Gross K, Martini M, Grichnik JM, Mihm M, Prieto VG, Googe P, King R, Toledano A, Kabelev N, Wojton M, Gutkowicz-Krusin D. The performance of MelaFind: a prospective multicenter study. Arch Dermatol. 2011 Feb.147(2):188-194. Pubmedid: 20956633.
  • Zalaudek I, Guelly C, Pellacani G, Hofmann-Wellenhof R, Trajanoski S, Kittler H, Scope A, Marghoob AA, Longo C, Leinweber B, Ferrara G, Saida T, Grichnik JM, Argenziano G, Becker JC. The dermoscopical and histopathological patterns of nevi correlate with the frequency of BRAF mutations. J Invest Dermatol. 2011 Feb.131(2):542-545. Pubmedid: 21068756.
  • Grichnik JM. Unrecognized sex-specific stress and behavior differences in patients with melanoma. Arch Dermatol. 2011 Feb.147(2):186. Pubmedid: 21339446.
  • Dosal J, Grichnik JM, Kirsner RS. Local actions of thyrotropin-releasing hormone regulate hair color. J Invest Dermatol. 2011 Dec.131(12):2340. Pubmedid: 22071537.
  • Slutsky JB, Rabinovitz H, Grichnik JM, Marghoob AA. Reflectance confocal microscopic features of dermatophytes, scabies, and demodex. Arch Dermatol. 2011 Aug.147(8):1008. Pubmedid: 21844478.
  • Grichnik JM. Stratum corneum RNA levels are diagnostic for melanoma. Br J Dermatol. 2011 Apr.164(4):693-694. Pubmedid: 21457197.
  • Puri PK, Valdes CL, Burchette JL, Grichnik JM, Turner JW, Selim MA. Accurate identification of proliferative index in melanocytic neoplasms with Melan-A/Ki-67 double stain. J Cutan Pathol. 2010 Sep.37(9):1010-1012. Pubmedid: 20002650.
  • Wang H, Chen X, Moss RH, Stanley RJ, Stoecker WV, Celebi ME, Szalapski TM, Malters JM, Grichnik JM, Marghoob AA, Rabinovitz HS, Menzies SW. Watershed segmentation of dermoscopy images using a watershed technique. Skin Res Technol. 2010 Aug.16(3):378-384. Pubmedid: 20637008. Pmcid: PMC3160671.
  • Celebi ME, Schaefer G, Iyatomi H, Stoecker WV, Malters JM, Grichnik JM. An improved objective evaluation measure for border detection in dermoscopy images. Skin Res Technol. 2009 Nov.15(4):444-450. Pubmedid: 19832956. Pmcid: PMC3159921.
  • Grichnik JM. Hypothesis letter: The reason sentinel and lymph node dissections do not improve melanoma mortality. J Invest Dermatol. 2009 Mar.129(3):779-781. Pubmedid: 18787537.
  • Cardones AR, Grichnik JM. alpha-Melanocyte-stimulating hormone-induced eruptive nevi. Arch Dermatol. 2009 Apr.145(4):441-444. Pubmedid: 19380666.
  • Fu D, Ye T, Matthews TE, Grichnik J, Hong L, Simon JD, Warren WS. Probing skin pigmentation changes with transient absorption imaging of eumelanin and pheomelanin. J Biomed Opt. 2008 Sep.13(5):054036. Pubmedid: 19021416.
  • Grichnik JM. Melanoma, nevogenesis, and stem cell biology. J Invest Dermatol. 2008 Oct.128(10):2365-2380. Pubmedid: 18787546.
  • Celebi ME, Kingravi HA, Iyatomi H, Aslandogan YA, Stoecker WV, Moss RH, Malters JM, Grichnik JM, Marghoob AA, Rabinovitz HS, Menzies SW. Border detection in dermoscopy images using statistical region merging. Skin Res Technol. 2008 Aug.14(3):347-353. Pubmedid: 19159382. Pmcid: PMC3160669.
  • Thomas MW, Grichnik JM, Izatt JA. Three-dimensional images and vessel rendering using optical coherence tomography. Arch Dermatol. 2007 Nov.143(11):1468-1469. Pubmedid: 18025387.
  • Miller SJ, Alam M, Andersen J, Berg D, Bichakjian CK, Bowen G, Cheney RT, Glass F, Grekin RC, Grichnik JM, Kessinger A, Lee NY, Lessin S, Lydiatt DD, Margolis LW, Michalski J, Nehal KS, Nghiem P, Oseroff AR, Rosenberg EW, Shaha AR, Siegle RJ, Urist MM. Dermatofibrosarcoma protuberans. J Natl Compr Canc Ne. 2007 May.5(5):550-555. Pubmedid: 17509257.
  • Miller SJ, Alam M, Andersen J, Berg D, Bichakjian CK, Bowen G, Cheney RT, Glass F, Grekin RC, Grichnik JM, Kessinger A, Lee NY, Lessin S, Lydiatt DD, Margolis LW, Michalski J, Nehal KS, Nghiem P, Oseroff AR, Rosenberg EW, Shaha AR, Siegle RJ, Urist MM. Basal cell and squamous cell skin cancers. J Natl Compr Canc Ne. 2007 May.5(5):506-529. Pubmedid: 17509254.
  • Grichnik JM. Sentinel-node biopsy in melanoma. N Engl J Med. 2007 Jan.356(4):418-419. Pubmedid: 17256188.
  • Bowling J, Argenziano G, Azenha A, Bandic J, Bergman R, Blum A, Cabo H, Di Stephani A, Grichnik J, Halpern A, Hofman-Wellenhof R, Johr R, Kittler H, Kopf A, Kreusch J, Langford D, Malvehy J, Marghoob A, Menzies S, Ozdemir F, Peris K, Piccolo D, Pizzichetta MA, Polsky D, Puig S, Rabinovitz H, Rubegni P, Saida T, Scalvenzi M, Seidenari S, Soyer HP, Tanaka M, Zalaudek I, Braun RP. Dermoscopy key points: recommendations from the international dermoscopy society. Dermatology. 2007.214(1):3-5. Pubmedid: 17191039.
  • Grichnik JM. Kit and melanocyte migration. J Invest Dermatol. 2006 May.126(5):945-947. Pubmedid: 16619010.
  • Walters RW, Grichnik JM. Follicular hyperkeratosis, hemorrhage, and corkscrew hair. Arch Dermatol. 2006 May.142(5):658. Pubmedid: 16702512.
  • Grichnik JM. Genomic instability and tumor stem cells. J Invest Dermatol. 2006 Jun.126(6):1214-1216. Pubmedid: 16702970.
  • Grichnik JM, Burch JA, Schulteis RD, Shan S, Liu J, Darrow TL, Vervaert CE, Seigler HF. Melanoma, a tumor based on a mutant stem cell?. J Invest Dermatol. 2006 Jan.126(1):142-153. Pubmedid: 16417230.
  • Miller SJ, Alam M, Andersen J, Berg D, Bichakjian CK, Bowen G, Cheney RT, Glass F, Grekin RC, Grichnik JM, Johnson TM, Kessinger A, Lee NY, Lessin S, Lydiatt DD, Margolis LW, Nehal KS, Nghiem P, Oseroff AR, Rosenberg EW, Shaha AR, Siegle RJ. Merkel cell carcinoma. J Natl Compr Canc Ne. 2006 Aug.4(7):704-712. Pubmedid: 16884672.
  • Lin FH, Lin JY, Gupta RD, Tournas JA, Burch JA, Selim MA, Monteiro-Riviere NA, Grichnik JM, Zielinski J, Pinnell SR. Ferulic acid stabilizes a solution of vitamins C and E and doubles its photoprotection of skin. J Invest Dermatol. 2005 Oct.125(4):826-832. Pubmedid: 16185284.
  • Lin JY, Lin FH, Burch JA, Selim MA, Monteiro-Riviere NA, Grichnik JM, Pinnell SR. Alpha-lipoic acid is ineffective as a topical antioxidant for photoprotection of skin. J Invest Dermatol. 2004 Nov.123(5):996-998. Pubmedid: 15482491.
  • Grichnik JM. Dermoscopy of melanocytic neoplasms: familial patterns. Arch Dermatol. 2004 May.140(5):642. Pubmedid: 15148119.
  • Grichnik JM. Dermoscopy of melanocytic neoplasms: subpatterns of dysplastic/atypical nevi. Arch Dermatol. 2004 Jan.140(1):142. Pubmedid: 14732678.
  • Grichnik JM. Dermoscopy of keratinocytic neoplasms: subpatterns of seborrheic keratoses. Arch Dermatol. 2004 Feb.140(2):260. Pubmedid: 14967809.
  • Grichnik JM. Dermoscopy of melanocytic neoplasms: subpatterns of dysplastic/atypical nevi. Arch Dermatol. 2003 Sep.139(9):1238. Pubmedid: 12975178.
  • Grichnik JM. Dermoscopy of melanocytic neoplasms: sclerotic blue nevi. Arch Dermatol. 2003 Nov.139(11):1522. Pubmedid: 14623720.
  • Argenziano G, Soyer HP, Chimenti S, Talamini R, Corona R, Sera F, Binder M, Cerroni L, De Rosa G, Ferrara G, Hofmann-Wellenhof R, Landthaler M, Menzies SW, Pehamberger H, Piccolo D, Rabinovitz HS, Schiffner R, Staibano S, Stolz W, Bartenjev I, Blum A, Braun R, Cabo H, Carli P, De Giorgi V, Fleming MG, Grichnik JM, Grin CM, Halpern AC, Johr R, Katz B, Kenet RO, Kittler H, Kreusch J, Malvehy J, Mazzocchetti G, Oliviero M, Ozdemir F, Peris K, Perotti R, Perusquia A, Pizzichetta MA, Puig S, Rao B, Rubegni P, Saida T, Scalvenzi M, Seidenari S, Stanganelli I, Tanaka M, Westerhoff K, Wolf IH, Braun-Falco O, Kerl H, Nishikawa T, Wolff K, Kopf AW. Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermatol. 2003 May.48(5):679-693. Pubmedid: 12734496.
  • Lucas CR, Sanders LL, Murray JC, Myers SA, Hall RP, Grichnik JM. Early melanoma detection: nonuniform dermoscopic features and growth. J Am Acad Dermatol. 2003 May.48(5):663-671. Pubmedid: 12734494.
  • Bellet JS, Grichnik JM. Surgilube as a replacement for oil during dermoscopic examination. Arch Dermatol. 2003 Mar.139(3):389. Pubmedid: 12622647.
  • Lin JY, Selim MA, Shea CR, Grichnik JM, Omar MM, Monteiro-Riviere NA, Pinnell SR. UV photoprotection by combination topical antioxidants vitamin C and vitamin E. J Am Acad Dermatol. 2003 Jun.48(6):866-874. Pubmedid: 12789176.
  • Lockhart A, Braun R, Yu D, Ross J, Dewhirst M, Klitzman B, Yuan F, Grichnik J, Proia A, Conway D, Mann G, Hurwitz H. A clinical model of dermal wound angiogenesis. Wound Repair Regen. 2003 Jul.11(4):306-313. Pubmedid: 12846919.
  • Bellet JS, Obadiah JM, Frothingham BM, Kurtzberg J, Grichnik JM. A patient with extensive stem cell factor-induced hyperpigmentation. Cutis. 2003 Feb.71(2):149-152. Pubmedid: 12635896.
  • Grichnik JM. Dermoscopy of melanocytic neoplasms: subpatterns of dysplastic/atypical nevi. Arch Dermatol. 2003 Dec.139(12):1696. Pubmedid: 14676098.
  • Grichnik JM. Dermoscopy of melanocytic neoplasms: subpatterns of melanoma. Arch Dermatol. 2003 Aug.139(8):1104. Pubmedid: 12925405.
  • Sober AJ, Chuang TY, Duvic M, Farmer ER, Grichnik JM, Halpern AC, Ho V, Holloway V, Hood AF, Johnson TM, Lowery BJ. Guidelines of care for primary cutaneous melanoma. J Am Acad Dermatol. 2001 Oct.45(4):579-586. Pubmedid: 11568750.
  • Yang S, Vervaert CE, Burch J, Grichnik J, Seigler HF, Darrow TL. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity. Int J Cancer. 1999 Nov.83(4):532-540. Pubmedid: 10508491.
  • Whited JD, Hall RP, Simel DL, Foy ME, Stechuchak KM, Drugge RJ, Grichnik JM, Myers SA, Horner RD. Reliability and accuracy of dermatologists' clinic-based and digital image consultations. J Am Acad Dermatol. 1999 Nov.41(5 Pt 1):693-702. Pubmedid: 10534630.
  • Whited JD, Grichnik JM. The rational clinical examination. Does this patient have a mole or a melanoma?. Jama. 1998 Mar.279(9):696-701. Pubmedid: 9496989.
  • Grichnik JM, Burch JA, Burchette J, Shea CR. The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis. J Invest Dermatol. 1998 Aug.111(2):233-238. Pubmedid: 9699723.
  • Wallace ML, Grichnik JM, Prieto VG, Shea CR. Numbers and differentiation status of melanocytes in idiopathic guttate hypomelanosis. J Cutan Pathol. 1998 Aug.25(7):375-379. Pubmedid: 9765023.
  • Whited JD, Mills BJ, Hall RP, Drugge RJ, Grichnik JM, Simel DL. A pilot trial of digital imaging in skin cancer. J Telemed Telecare. 1998.4(2):108-112. Pubmedid: 9744167.
  • Grichnik JM, Ali WN, Burch JA, Byers JD, Garcia CA, Clark RE, Shea CR. KIT expression reveals a population of precursor melanocytes in human skin. J Invest Dermatol. 1996 May.106(5):967-971. Pubmedid: 8618059.
  • Jimenez FJ, Burchette JL, Grichnik JM, Hitchcock MG. Ber-EP4 immunoreactivity in normal skin and cutaneous neoplasms. Mod Pathol. 1995 Oct.8(8):854-858. Pubmedid: 8552575.
  • Grichnik JM, Crawford J, Jimenez F, Kurtzberg J, Buchanan M, Blackwell S, Clark RE, Hitchcock MG. Human recombinant stem-cell factor induces melanocytic hyperplasia in susceptible patients. J Am Acad Dermatol. 1995 Oct.33(4):577-583. Pubmedid: 7545704.
  • Jimenez FJ, Grichnik JM, Buchanan MD, Clark RE. Immunohistochemical techniques in Mohs micrographic surgery: their potential use in the detection of neoplastic cells masked by inflammation. J Am Acad Dermatol. 1995 Jan.32(1):89-94. Pubmedid: 7529778.
  • Jimenez FJ, Grichnik JM, Buchanan MD, Clark RE. Immunohistochemical margin control applied to Mohs micrographic surgical excision of dermatofibrosarcoma protuberans. J Dermatol Surg Oncol. 1994 Oct.20(10):687-689. Pubmedid: 7523470.
  • Grichnik JM, Gilchrest BA. A novel approach to analysis of transcriptional regulation in human cells: initial application to melanocytes and melanoma cells. J Invest Dermatol. 1991 May.96(5):742-746. Pubmedid: 1850774.
  • Grichnik JM, Bergsma DJ, Schwartz RJ. Tissue restricted and stage specific transcription is maintained within 411 nucleotides flanking the 5' end of the chicken alpha-skeletal actin gene. Nucleic Acids Res. 1986 Feb.14(4):1683-1701. Pubmedid: 3005979. Pmcid: PMC339560.

Patient Comments
Overall Satisfaction
0
★★★★★
★★★★★

0 patients rated this provider

The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. These surveys assess the experience of our patients when visiting us for an Outpatient Clinic, Urgent Care or Virtual Health (Telemedicine) visit. Responses are measured on a scale of 1 to 5 with 5 being the best score.

Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Learn more about our patient satisfaction survey

Comments ()

Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.

We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.

Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.

Learn more about our patient comments

Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:

  • The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 30 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
  • He or she may be a researcher or other type of provider that does not see patients.
  • The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.
Learn more about our patient satisfaction survey, ratings and comments